February 13, 2007

Pharmaceutical Company Wins
Texas MOOT CORP^® Competition

AUSTIN, Texas—MacuCLEAR Corp., a pharmaceutical company that has developed a treatment for age-related macular degeneration (AMD), the leading cause of blindness in people over the age of 50, defeated three teams Feb. 9 to win the Texas round of Moot Corp®, the prestigious venture competition hosted annually at The University of Texas at Austin’s McCombs School of Business.

“The judges had a tough decision. All four teams represented companies with viable investment potential,” said Rob Adams, director of Moot Corp and management lecturer at McCombs.

Christopher R. Aniszczyk, graduate student of science and technology commercialization, addresses the Moot Corp judges on behalf of MacuCLEAR Feb. 9 at the McCombs School of Business.

As winner of the Texas round, MacuCLEAR qualifies to receive a year’s office space in the Austin Technology Incubator and advancement to the Global Moot Corp Competition in Austin May 3-5, 2007. It is expected to draw 35 teams from around the world vying for cash and prizes worth up to $100,000.

“Participating in the Texas Moot Corp Competition has been a great experience,” said Doug Baum, executive vice president of MacuCLEAR. “We will take the lessons we have learned forward to help us move closer to gaining funding.”

Started by MBA students at The University of Texas at Austin in 1984, Moot Corp is the oldest new venture competition in the world, and continues to provide MBA student teams with a chance to simulate the process of raising venture capital. 

For more information, contact Ann Whitt at Ann.Whitt@mccombs.utexas.edu or at (512) 232-6597. 
 

 

E-mail this page

Print this page